Abstract

Mast cells localize to mucosal tissues and contribute to innate immune defense against infection. How mast cells sense, differentiate between, and respond to bacterial pathogens remains a topic of ongoing debate. Using the prototype enteropathogen Salmonella Typhimurium (S.Tm) and other related enterobacteria, here we show that mast cells can regulate their cytokine secretion response to distinguish between extracellular and invasive bacterial infection. Tissue-invasive S.Tm and mast cells colocalize in the mouse gut during acute Salmonella infection. Toll-like Receptor 4 (TLR4) sensing of extracellular S.Tm, or pure lipopolysaccharide, causes a modest induction of cytokine transcripts and proteins, including IL-6, IL-13, and TNF. By contrast, type-III-secretion-system-1 (TTSS-1)-dependent S.Tm invasion of both mouse and human mast cells triggers rapid and potent inflammatory gene expression and >100-fold elevated cytokine secretion. The S.Tm TTSS-1 effectors SopB, SopE, and SopE2 here elicit a second activation signal, including Akt phosphorylation downstream of effector translocation, which combines with TLR activation to drive the full-blown mast cell response. Supernatants from S.Tm-infected mast cells boost macrophage survival and maturation from bone-marrow progenitors. Taken together, this study shows that mast cells can differentiate between extracellular and host-cell invasive enterobacteria via a two-step activation mechanism and tune their inflammatory output accordingly.

Mast cells serve as sentinels for mucosal infection. This study shows how mast cells can differentially detect extracellular and invasive gut bacteria, and in response tune their cytokine production to signal different levels of danger.

Details

Title
A two-step activation mechanism enables mast cells to differentiate their response between extracellular and invasive enterobacterial infection
Author
von Beek, Christopher 1   VIAFID ORCID Logo  ; Fahlgren, Anna 2 ; Geiser, Petra 1   VIAFID ORCID Logo  ; Di Martino, Maria Letizia 1   VIAFID ORCID Logo  ; Lindahl, Otto 1   VIAFID ORCID Logo  ; Prensa, Grisna I. 1   VIAFID ORCID Logo  ; Mendez-Enriquez, Erika 1   VIAFID ORCID Logo  ; Eriksson, Jens 1   VIAFID ORCID Logo  ; Hallgren, Jenny 1   VIAFID ORCID Logo  ; Fällman, Maria 2   VIAFID ORCID Logo  ; Pejler, Gunnar 1 ; Sellin, Mikael E. 3   VIAFID ORCID Logo 

 Uppsala University, Department of Medical Biochemistry and Microbiology, Uppsala, Sweden (GRID:grid.8993.b) (ISNI:0000 0004 1936 9457) 
 Umeå University, Department of Molecular Biology, Laboratory for Molecular Infection Medicine Sweden (MIMS), Umeå Centre for Microbial Research (UCMR), Umeå, Sweden (GRID:grid.12650.30) (ISNI:0000 0001 1034 3451) 
 Uppsala University, Department of Medical Biochemistry and Microbiology, Uppsala, Sweden (GRID:grid.8993.b) (ISNI:0000 0004 1936 9457); Science for Life Laboratory, Uppsala, Sweden (GRID:grid.452834.c) (ISNI:0000 0004 5911 2402) 
Pages
904
Publication year
2024
Publication date
2024
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2919970175
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.